Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
MDA Breakout Stocks Week 10 - March 2023: High-Frequency Gainers To Give You An Edge
06:56am, Sunday, 05'th Mar 2023
Two new Breakout Stocks for Week 10 with better than 10% short-term upside and a Dow 30 Picks. Average cumulative returns for 2023 are +38.0% YTD. The Momentum Gauges® were negative from Week 8 with
5 Relatively Safe And Cheap Dividend Stocks To Invest In - March 2023
09:30am, Saturday, 04'th Mar 2023
This article is part of our monthly series where we highlight five companies that are large-cap, relatively safe, dividend-paying, and are offering large discounts to their historical norms. We go ove
Is Trending Stock Merck & Co., Inc. (MRK) a Buy Now?
10:33am, Friday, 03'rd Mar 2023
Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
The Most-Sold Guru Stocks of the 4th Quarter
10:12am, Friday, 03'rd Mar 2023
The fourth quarter of 2022 marked a slight recovery for equity markets as they recouped some of their losses from the rest of the year. The S&P 500 climbed 7.6% for the quarter to end the year with a
This Top Fund Manager Expects A Big Drop In Stocks
07:00am, Friday, 03'rd Mar 2023
Eli Salzmann, manager of the Neuberger Berman Large Cap Value Fund (NPRTX), doesn't expect the early-year stock market rally to last. The post This Top Fund Manager Expects A Big Drop In Stocks appear
Merck: All Eyes On Key Clinical Catalyst In March
01:40pm, Tuesday, 28'th Feb 2023
Merck is an American biopharma powerhouse that has generated consistent compounding growth, increasing its top line and EPS. Merck expects to deploy capital through strategic small bolt-on acquisition
What is the Best Dividend ETF?
07:11am, Tuesday, 28'th Feb 2023
In saying that, some dividend ETFs stand head and shoulders above others, measured by their total return. In this case, the best dividend ETF is the Schwab U.S. Dividend Equity ETF (NYSEARCA: SCHD), w
Merck Stock Looks Better Priced Compared To Its Sector Peer
06:00am, Tuesday, 28'th Feb 2023
Although investors have assigned a higher P/S multiple for LLY stock owing to its pipeline potential, we believe this gap will narrow in favor of Merck.
MDA Breakout Stocks Week 9 - March 2023: High-Frequency Gainers To Give You An Edge
09:37am, Sunday, 26'th Feb 2023
Two new Breakout Stocks for Week 9 with better than 10% short-term upside and a Dow 30 Pick. Average cumulative returns for 2023 are +35.8% YTD. This week, the Momentum Gauges® turned negative for th
3 Biotech Stocks To Watch Ahead Of March 2023
03:44pm, Saturday, 25'th Feb 2023
Do you have these three biotech stocks on your watchlist right now?
WHO panel is reviewing whether COVID vaccines need to be updated
06:01pm, Friday, 24'th Feb 2023 MarketWatch
Most of the week's COVID news is focused on vaccines, including the big slide in Moderna's revenue caused by falling demand.
Pharma Stock Roundup: FDA Updates for SNY, PFE & Others, EU Nod to AZN Cancer Combo
03:30pm, Friday, 24'th Feb 2023 Zacks Investment Research
FDA approves Sanofi's (SNY) Altuviiio and grants a priority tag to Pfizer's (PFE) regulatory applications for pipeline candidates.
Stock Market News for Feb 24, 2023
02:04pm, Friday, 24'th Feb 2023 Zacks Investment Research
U.S. stock markets closed higher on Thursday after a choppy session.
Moderna’s stock slides as earnings fall short of estimates
12:09pm, Friday, 24'th Feb 2023 MarketWatch
With the boost Moderna got from COVID vaccines now fading, analysts are focused on the company's pipeline.
Don't Get Panicked Into Selling Off Merck Shares
11:45am, Friday, 24'th Feb 2023 The Motley Fool
The current drop in 2023 sales likely won't matter in the long term.
